1. Home
  2. ADPT vs MLR Comparison

ADPT vs MLR Comparison

Compare ADPT & MLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • MLR
  • Stock Information
  • Founded
  • ADPT 2009
  • MLR 1990
  • Country
  • ADPT United States
  • MLR United States
  • Employees
  • ADPT N/A
  • MLR N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • MLR Construction/Ag Equipment/Trucks
  • Sector
  • ADPT Health Care
  • MLR Consumer Discretionary
  • Exchange
  • ADPT Nasdaq
  • MLR Nasdaq
  • Market Cap
  • ADPT 929.8M
  • MLR 769.3M
  • IPO Year
  • ADPT 2019
  • MLR 1994
  • Fundamental
  • Price
  • ADPT $6.81
  • MLR $67.91
  • Analyst Decision
  • ADPT Buy
  • MLR Strong Buy
  • Analyst Count
  • ADPT 4
  • MLR 1
  • Target Price
  • ADPT $6.75
  • MLR $82.00
  • AVG Volume (30 Days)
  • ADPT 1.3M
  • MLR 72.5K
  • Earning Date
  • ADPT 02-12-2025
  • MLR 03-05-2025
  • Dividend Yield
  • ADPT N/A
  • MLR 1.12%
  • EPS Growth
  • ADPT N/A
  • MLR 35.81
  • EPS
  • ADPT N/A
  • MLR 6.02
  • Revenue
  • ADPT $177,282,000.00
  • MLR $1,331,839,000.00
  • Revenue This Year
  • ADPT $6.48
  • MLR $16.10
  • Revenue Next Year
  • ADPT $18.72
  • MLR $6.72
  • P/E Ratio
  • ADPT N/A
  • MLR $11.28
  • Revenue Growth
  • ADPT N/A
  • MLR 22.98
  • 52 Week Low
  • ADPT $2.28
  • MLR $38.61
  • 52 Week High
  • ADPT $7.46
  • MLR $78.25
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 54.92
  • MLR 52.25
  • Support Level
  • ADPT $5.98
  • MLR $62.25
  • Resistance Level
  • ADPT $7.28
  • MLR $67.77
  • Average True Range (ATR)
  • ADPT 0.54
  • MLR 1.59
  • MACD
  • ADPT -0.00
  • MLR 0.37
  • Stochastic Oscillator
  • ADPT 58.06
  • MLR 82.03

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About MLR Miller Industries Inc.

Miller Industries Inc is engaged in the manufacturing of vehicle towing and recovery equipment. The company produces wreckers, car carriers, and trailer bodies under the Century, Vulcan, Challenger, Holmes, Champion, Chevron, Eagle, Titan, Jige, and Boniface brands. The products are sold in North America, Canada, and Mexico through independent distributors.

Share on Social Networks: